|
|
Issue
|
Alert me when new journal issues are available via  or via  |
|
|
| Alzheimer's & Dementia: The Journal of the Alzheimer's Association |
| Volume 2, Issue 3, Pages 131-262 (July 2006) |
|
Search Within This Issue
|
|
|
|
|
|
|
 =free full text
|
|
|
|
Perspectives
|
|
Optimal design of clinical trials for drugs designed to slow the course of Alzheimer’s disease
Richard C. Mohs, Claudia Kawas, Maria C. Carrillo
pages 131-139
Abstract |
Full Text |
Full-Text PDF (188 KB)
|
|
Commentary on “Optimal design of clinical trials for drugs designed to slow the course of Alzheimer’s disease”
Eric R. Siemers
pages 140-142
Full Text |
Full-Text PDF (71 KB)
|
|
Disease modification in multiple sclerosis: Issues with relevance to clinical trial designs in Alzheimer’s disease
Richard A. Rudick
pages 143-146
Abstract |
Full Text |
Full-Text PDF (185 KB)
|
|
Finding potent drugs for Alzheimer’s disease is more important than proving the drugs are disease modifying
David Knopman
pages 147-149
Abstract |
Full Text |
Full-Text PDF (81 KB)
|
|
Disease-modifying treatments for Alzheimer’s disease: A perspective based on experience with R-Flurbiprofen
Gordon K. Wilcock
pages 150-152
Full Text |
Full-Text PDF (67 KB)
|
|
Development of a disease-modifying treatment for Alzheimer’s disease: Alzhemed
Paul S. Aisen
pages 153-154
Full Text |
Full-Text PDF (61 KB)
|
|
Lessons from osteoporosis clinical trials
Stuart L. Silverman
pages 155-159
Abstract |
Full Text |
Full-Text PDF (90 KB)
|
|
Perspectives on assessing benefits and risks in clinical trials for Alzheimer’s disease
Stephen McConnell, Jason Karlawish, Bruno Vellas, Steven DeKosky
pages 160-163
Abstract |
Full Text |
Full-Text PDF (78 KB)
|
|
Telomeres and telomerase in Alzheimer’s disease: Epiphenomena or a new focus for therapeutic strategy?
Sonia Franco, Maria A. Blasco, Sandra L. Siedlak, Peggy L.R. Harris, Paula I. Moreira, George Perry, Mark A. Smith
pages 164-168
Abstract |
Full Text |
Full-Text PDF (238 KB)
|
|
Commentary on “Comparison of clinical and neuropathologic diagnoses of Alzheimer’s disease in 3 epidemiologic samples”
Kurt A. Jellinger
pages 169-170
Full Text |
Full-Text PDF (62 KB)
|
|
|
Featured Articles
|
|
The reciprocal risks of stroke and cognitive impairment in an elderly population
Ya-Ping Jin, Silvia Di Legge, Truls Ostbye, John W. Feightner, Vladimir Hachinski
pages 171-178
Abstract |
Full Text |
Full-Text PDF (325 KB)
|
|
Telemedicine, dementia and Down syndrome: Implications for Alzheimer disease
Ira T. Lott, Eric Doran, David M. Walsh, Mary Ann Hill
pages 179-184
Abstract |
Full Text |
Full-Text PDF (114 KB)
|
|
|
Review Articles
|
|
Vascular cognitive impairment: Today and tomorrow
Helena Chang Chui
pages 185-194
Abstract |
Full Text |
Full-Text PDF (169 KB)
|
|
Commentary on “Vascular cognitive impairment: Today and tomorrow”
Lewis H. Kuller
pages 195-197
Full Text |
Full-Text PDF (72 KB)
|
|
Commentary on “Vascular cognitive impairment: Today and tomorrow.” Vascular cognitive impairment: Yesterday, today, and tomorrow
Vladimir Hachinski
pages 198-199
Full Text |
Full-Text PDF (60 KB)
|
|
Commentary on “Vascular cognitive impairment: Today and tomorrow”
Oscar L. Lopez
pages 200-201
Full Text |
Full-Text PDF (66 KB)
|
|
Commentary on “Vascular cognitive impairment: Today and tomorrow.” Vascular cognitive impairment: Time for prevention?
Laura Fratiglioni, Chengxuan Qiu, Katie Palmer
pages 202-204
Full Text |
Full-Text PDF (75 KB)
|
|
Commentary on “Vascular cognitive impairment: Today and tomorrow”
William R. Markesbery
pages 205-206
Full Text |
Full-Text PDF (61 KB)
|
|
Commentary on “Vascular cognitive impairment: Today and tomorrow”
David A. Bennett
pages 207-209
Full Text |
Full-Text PDF (74 KB)
|
|
Aggressive course of disease in dementia
Serge Gauthier, Bruno Vellas, Martin Farlow, David Burn
pages 210-217
Abstract |
Full Text |
Full-Text PDF (268 KB)
|
|
Commentary on “Aggressive course of disease in dementia”
Jason Brandt
pages 218-219
Full Text |
Full-Text PDF (61 KB)
|
|
Alzheimer’s Association Research Roundtable Meeting on Mild Cognitive Impairment: What have we learned?
Michael Grundman, Ronald C. Petersen, David A. Bennett, Howard H. Feldman, Stephen Salloway, Pieter Jelle Visser, Leon J. Thal, Dale Schenk, Zaven Khachaturian, William Thies, Alzheimer’s Association Research Roundtable
pages 220-233
Abstract |
Full Text |
Full-Text PDF (243 KB)
|
|
Factors associated with gastrostomy tube feeding in dementia: A structured literature review
Elizabeth W. Jones, Lauris C. Kaldjian, Valerie Forman-Hoffman
pages 234-242
Full Text |
Full-Text PDF (184 KB)
|
|
|
Policy Forum
|
|
Policy statement on voting by persons with dementia residing in long-term care facilities
Jason Karlawish, Paul S. Appelbaum, Richard Bonnie, Pamela Karlan, Stephen McConnell
pages 243-245
Full Text |
Full-Text PDF (73 KB)
|
|
|
Meeting Report
|
|
A review of the “State of the Art” on Mild Cognitive Impairment: The Fourth Annual Symposium
Lisa J. Bain
pages 246-256
Abstract |
Full Text |
Full-Text PDF (147 KB)
|
|
|
Research News
|
|
Modifying dementia risk and trajectories of cognitive decline in aging: The Cache County Memory Study
Kathleen A. Welsh-Bohmer, John C.S. Breitner, Kathleen M. Hayden, Constantine Lyketsos, Peter P. Zandi, JoAnn T. Tschanz, Maria C. Norton, Ron Munger
pages 257-260
Abstract |
Full Text |
Full-Text PDF (88 KB)
|
|
|
Correspondence
|
|
Correspondence
Vladimir Hachinski
page 261
Full Text |
Full-Text PDF (43 KB)
|
|
|
Frontmatter
|
|
Subscriber information page
page A2
Full Text |
Full-Text PDF (43 KB)
|
|
Contents
page A3
Full Text |
Full-Text PDF (42 KB)
|
|
Contents
page A4
Full Text |
Full-Text PDF (30 KB)
|
|
Editorial board
page A7
Full Text |
Full-Text PDF (39 KB)
|
|
Alzheimer’s Association Medical and Scientific Advisory Council
page A11
Full Text |
Full-Text PDF (35 KB)
|
|
Information for Authors
pages A13-A15
Full Text |
Full-Text PDF (71 KB)
|
|
|
ALZHEIMER'S ASSOCIATION Update
|
|
Research Roundtable Designates Grant, Hosts Invited Meeting on Diverse Treatment Strategies
pages A17-A18
Full Text |
Full-Text PDF (62 KB)
|
|
|
|
|
